- Oral presentation
- Open Access
Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
© Sado et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Late Gadolinium Enhancement
- Iron Overload
- Hypertrophic Cardiomyopathy
- Fabry Disease
T1 mapping is a powerful technique for ECV quantification; native T1 has been shown to increase in a variety of conditions including oedema, fibrosis and amyloid. Iron and fat lower T1. Anderson Fabry disease (AFD) is a fat storage disease, cardiac iron occurs in transfusion dependent patients. We hypothesised that T1 lowering would diagnose early cardiac involvement, track disease severity and discriminate from other mimic pathologies.
280 subjects were studied: iron overload (n=53), AFD (n=44, 55% with LVH, all genotyped), healthy volunteers (HV, n=67, 0% with LVH), hypertension (HYP, n=41, 24% with LVH), hypertrophic cardiomyopathy (HCM, n=34, 100% with LVH), severe aortic stenosis (AS, n=21, 81% with LVH) and definite AL cardiac amyloidosis (AMY, n=20, 100% with LVH). Along with routine clinical CMR, native, non-contrast T1 mapping was performed using the Sh-MOLLI technique at 1.5T without gadolinium administration. T2*(iron overload) and LGE and LV mass (AFD and LVH diseases) were also assessed.
Compared to health volunteers, septal T1 was lower in iron overload and AFD and higher in other diseases (iron overload vs AFD vs healthy volunteers vs other patients, 836±138 ms, 882±47 ms, 968±32 ms, 1018±74 ms, P<0.0001).
Impressive lowering of myocardial T1 can occur in AFD and particularly iron overloading. Unsuspected cardiac involvement was found in 40% of AFD patients without LVH and 25% of possible iron overload patients where T2*was normal. When compared to the common causes of LVH, the detection of T1 lowering appears definitively diagnostic of AFD.
British Heart Foundation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.